Analyze Diet
Veterinary parasitology2018; 259; 53-60; doi: 10.1016/j.vetpar.2018.07.003

Anthelmintic efficacy against equine strongyles in the United States.

Abstract: Equine strongyle parasites are ubiquitous in grazing equids across the world. Anthelmintic resistance is widely developed in cyathostomin populations, but very few surveys have evaluated anthelmintic efficacy in equine populations in the United States, and most of these are over 15 years old. The present study was carried out as part of the National Animal Health Monitoring Systems (NAHMS) Equine 2015-2016 study. The aims were to investigate anthelmintic treatment efficacy by means of the fecal egg count reduction test (FECRT) and identify parameters associated with decreased efficacy. Data were collected from equine operations in 28 states via questionnaires and fecal samples submitted for fecal egg count analysis. Participants were instructed to collect samples from six equids at the day of anthelmintic treatments and 14 days later, and they were asked to include an empty syringe with a legible label of the anthelmintic product used in the shipment. Overall, dewormer treatment was effective for 76.3% of operations (84.6% of animals). Macrocyclic lactone use was effective for 88.7% of operations (95.0% of animals) while pyrimidine/benzimidazole use was effective for 21.4% of operations (43.5% of animals). Univariate analysis revealed that overall, macrocyclic lactones exhibited significantly higher efficacy than the pyrimidine and benzimidazole drug classes (p < 0.0001). There were no statistically significant differences observed between geographic regions (West, South Central, North East, and Southeast). Body weight (p = 0.0355), amount of anthelmintic administered (p = 0.0119), and operation size (p = 0.0162) were statistically associated with anthelmintic efficacy, while anthelmintic treatment frequency in the previous 12 months was not (p = 0.7081). Multiple, mixed-effect logistic regression revealed that anthelmintic drug class (p < 0.0001) was the most impactful factor in predicting anthelmintic efficacy, after accounting for operation size, region and clustering of equids at the operation level. Pasture rotation (p = 0.0129) also demonstrated a significant effect using this model. These data document widespread occurrence of reduced anthelmintic efficacy of benzimidazole and pyrimidine products against strongyle infections in equids in the United States. Anthelmintic efficacy patterns were relatively uniform between the four studied regions, and some epidemiological factors were identified to be associated with anthelmintic efficacy against strongyle infections. This information can be useful in devising sustainable parasite control strategies in the future.
Publication Date: 2018-07-06 PubMed ID: 30056984DOI: 10.1016/j.vetpar.2018.07.003Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study addresses anthelmintic resistance in equine strongyle parasites in the United States. Through fecal egg count reduction tests, the researchers evaluated the efficacy of different deworming treatments, revealing a majority success rate but also highlighting concerns in certain areas, particularly with benzimidazole and pyrimidine products.

Research Methods

  • The study was part of the National Animal Health Monitoring Systems (NAHMS) Equine 2015-2016 study.
  • Anthelmintic treatment efficacy was measured using the fecal egg count reduction test (FECRT).
  • Data were collected through questionnaires and fecal samples from equine operations in 28 states.
  • Participants collected samples before and 14 days after anthelmintic treatments, and provided an empty syringe of the anthelmintic used.

Main Findings

  • Deworming treatment was effective for 76.3% of operations overall (84.6% of individual animals).
  • The use of macrocyclic lactone anthelmintics was effective for 88.7% of operations (95.0% of animals).
  • The use of pyrimidine/benzimidazole anthelmintics was effective for only 21.4% of operations (43.5% of animals).
  • Univariate analysis revealed a significantly higher efficacy for macrocyclic lactones than the pyrimidine and benzimidazole drug classes (p < 0.0001).
  • There were no statistically significant differences in anthelmintic efficacy between geographic regions (West, South Central, North East, and Southeast).

Parameters Impacting Efficacy

  • Body weight, amount of anthelmintic administered, and operation size were statistically associated with anthelmintic efficacy.
  • Anthelmintic treatment frequency in the previous 12 months did not impact efficacy.
  • Multiple, mixed-effect logistic regression revealed that anthelmintic drug class had the most significant impact on predicting anthelmintic efficacy.
  • Pasture rotation also had a significant effect on treatment efficacy.

Implications

  • The study documents widespread reduced efficacy of benzimidazole and pyrimidine products against strongyle infections in equids in the United States.
  • The patterns of anthelmintic efficacy were largely uniform across regions, with certain epidemiological factors being associated with treatment success.
  • The findings can potentially contribute to better strategies for sustainable parasite control in the future.

Cite This Article

APA
Nielsen MK, Branan MA, Wiedenheft AM, Digianantonio R, Scare JA, Bellaw JL, Garber LP, Kopral CA, Phillippi-Taylor AM, Traub-Dargatz JL. (2018). Anthelmintic efficacy against equine strongyles in the United States. Vet Parasitol, 259, 53-60. https://doi.org/10.1016/j.vetpar.2018.07.003

Publication

ISSN: 1873-2550
NlmUniqueID: 7602745
Country: Netherlands
Language: English
Volume: 259
Pages: 53-60

Researcher Affiliations

Nielsen, M K
  • M.H Gluck Equine Research Center, Department of Veterinary Science, University of Kentucky, Lexington, USA. Electronic address: martin.nielsen@uky.edu.
Branan, M A
  • USDA-APHIS-VS-STAS Center for Epidemiology and Animal Health, National Animal Health Monitoring System, Fort Collins, CO, USA.
Wiedenheft, A M
  • Colorado State University, College of Veterinary Medicine and Biomedical Sciences, Fort Collins, CO, USA.
Digianantonio, R
  • Colorado State University, College of Veterinary Medicine and Biomedical Sciences, Fort Collins, CO, USA.
Scare, J A
  • M.H Gluck Equine Research Center, Department of Veterinary Science, University of Kentucky, Lexington, USA.
Bellaw, J L
  • M.H Gluck Equine Research Center, Department of Veterinary Science, University of Kentucky, Lexington, USA.
Garber, L P
  • USDA-APHIS-VS-STAS Center for Epidemiology and Animal Health, National Animal Health Monitoring System, Fort Collins, CO, USA.
Kopral, C A
  • USDA-APHIS-VS-STAS Center for Epidemiology and Animal Health, National Animal Health Monitoring System, Fort Collins, CO, USA.
Phillippi-Taylor, A M
  • Division of Therapeutic Drugs for Non-Food Animals, Center for Veterinary Medicine, FDA, Rockville, MD, USA.
Traub-Dargatz, J L
  • Colorado State University, College of Veterinary Medicine and Biomedical Sciences, Fort Collins, CO, USA.

MeSH Terms

  • Animals
  • Anthelmintics / adverse effects
  • Anthelmintics / therapeutic use
  • Benzimidazoles / adverse effects
  • Benzimidazoles / therapeutic use
  • Communicable Disease Control / methods
  • Communicable Disease Control / statistics & numerical data
  • Drug Resistance
  • Feces / parasitology
  • Horse Diseases / drug therapy
  • Horse Diseases / epidemiology
  • Horse Diseases / parasitology
  • Horses / parasitology
  • Ivermectin / adverse effects
  • Ivermectin / therapeutic use
  • Parasite Egg Count / methods
  • Parasite Egg Count / statistics & numerical data
  • Parasite Egg Count / veterinary
  • Pyrimidines / adverse effects
  • Pyrimidines / therapeutic use
  • Strongyle Infections, Equine / drug therapy
  • Strongyle Infections, Equine / epidemiology
  • Strongyle Infections, Equine / parasitology
  • Strongyloidea / drug effects
  • Surveys and Questionnaires
  • Treatment Outcome
  • United States / epidemiology